| 1. Nagel AA, Liston DR, Jung S, Mahar M, Vincent LA, Chapin D, Chen YL, Hubbard S, Ives JL, Jones SB.. (1995) Design and synthesis of 1-heteroaryl-3-(1-benzyl-4-piperidinyl)propan-1-one derivatives as potent, selective acetylcholinesterase inhibitors., 38 (7): [PMID:7707311] [10.1021/jm00007a005] |
| 2. Bolognesi ML, Andrisano V, Bartolini M, Minarini A, Rosini M, Tumiatti V, Melchiorre C.. (2001) Hexahydrochromeno[4,3-b]pyrrole derivatives as acetylcholinesterase inhibitors., 44 (1): [PMID:11141093] [10.1021/jm000991r] |
| 3. Sowell JW, Tang Y, Valli MJ, Chapman JM, Usher LA, Vaughan CM, Kosh JW.. (1992) Synthesis and cholinergic properties of bis[[(dimethylamino)methyl]furanyl] analogues of ranitidine., 35 (6): [PMID:1552502] [10.1021/jm00084a015] |
| 4. Ronzani N, Lajat M. (1995) Acetylcholinesterase inhibition by alkaloids of the ant's venom Monomorium minutum, 5 (11): [10.1016/0960-894X(95)00179-W] |
| 5. Ares JJ, Ronkin SM, Wallace LJ. (1992) Synthesis of 1-(2-Indolyl)pyridinium salts: a prodrug approach to acetylcholinesterase inhibition, 2 (2): [10.1016/S0960-894X(01)80432-7] |
| 6. Chen YL, Nielsen J, Hedberg K, Dunaiskis A, Jones S, Russo L, Johnson J, Ives J, Liston D.. (1992) Syntheses, resolution, and structure-activity relationships of potent acetylcholinesterase inhibitors: 8-carbaphysostigmine analogues., 35 (8): [PMID:1573636] [10.1021/jm00086a011] |
| 7. Leader H, Smejkal RM, Payne CS, Padilla FN, Doctor BP, Gordon RK, Chiang PK.. (1989) Binary antidotes for organophosphate poisoning: aprophen analogues that are both antimuscarinics and carbamates., 32 (7): [PMID:2738887] [10.1021/jm00127a020] |
| 8. Cannon JG, Sahin MF, Bhatnagar RK, Flynn JR, Long JP.. (1991) Structure-activity studies on a potent antagonist to organophosphate-induced toxicity., 34 (5): [PMID:2033583] [10.1021/jm00109a009] |
| 9. Chen YL, Liston D, Nielsen J, Chapin D, Dunaiskis A, Hedberg K, Ives J, Johnson J, Jones S.. (1994) Syntheses and anticholinesterase activity of tetrahydrobenzazepine carbamates., 37 (13): [PMID:8027982] [10.1021/jm00039a013] |
| 10. Alisi MA, Brufani M, Filocamo L, Gostoli G, Licandro E, Cesta M, Lappa S, Marchesini D, Pagella P. (1995) Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: Morpholinoalkylcarbamoyloxyeseroline derivatives, 5 (18): [10.1016/0960-894X(95)00371-Y] |
| 11. Doll F, Dolci L, Valette H, Hinnen F, Vaufrey F, Guenther I, Fuseau C, Coulon C, Bottlaender M, Crouzel C.. (1999) Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors., 42 (12): [PMID:10377231] [10.1021/jm9910223] |
| 12. Yu QS, Atack JR, Rapoport SI, Brossi A.. (1988) Synthesis and anticholinesterase activity of (-)-N1-norphysostigmine, (-)-eseramine, and other N(1)-substituted analogues of (-)-physostigmine., 31 (12): [PMID:3193422] [10.1021/jm00120a008] |
| 13. Brossi A.. (1990) Alfred Burger award address. Bioactive alkaloids. 4. Results of recent investigations with colchicine and physostigmine., 33 (9): [PMID:2202827] [10.1021/jm00171a001] |
| 14. Brossi A.. (1990) Alfred Burger award address. Bioactive alkaloids. 4. Results of recent investigations with colchicine and physostigmine., 33 (9): [PMID:2202827] [10.1021/jm00171a001] |
| 15. Yu Q, Greig NH, Holloway HW, Brossi A.. (1998) Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine., 41 (13): [PMID:9632370] [10.1021/jm9800494] |
| 16. Villalobos A, Blake JF, Biggers CK, Butler TW, Chapin DS, Chen YL, Ives JL, Jones SB, Liston DR, Nagel AA.. (1994) Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase., 37 (17): [PMID:8064800] [10.1021/jm00043a012] |
| 17. Lin G, Chen GH, Ho HC.. (1998) Conformationally restricted carbamate inhibitors of horse serum butyrylcholinesterase., 8 (19): [PMID:9873615] [10.1016/s0960-894x(98)00484-3] |
| 18. Bruno-Blanch L, Gálvez J, García-Domenech R.. (2003) Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity., 13 (16): [PMID:12873507] [10.1016/s0960-894x(03)00535-3] |
| 19. Villalobos A, Butler TW, Chapin DS, Chen YL, DeMattos SB, Ives JL, Jones SB, Liston DR, Nagel AA, Nason DM.. (1995) 5,7-dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6H- pyrrolo[3,2-f]-1,2-benzisoxazol-6-one: a potent and centrally-selective inhibitor of acetylcholinesterase with an improved margin of safety., 38 (15): [PMID:7636841] [10.1021/jm00015a002] |
| 20. Yu QS, Pei XF, Holloway HW, Greig NH, Brossi A.. (1997) Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues., 40 (18): [PMID:9288171] [10.1021/jm970210v] |
| 21. Vidaluc JL, Calmel F, Bigg DC, Carilla E, Briley M.. (1995) Flexible 1-[(2-aminoethoxy)alkyl]-3-ar(o)yl(thio)ureas as novel acetylcholinesterase inhibitors. Synthesis and biochemical evaluation., 38 (15): [PMID:7636858] [10.1021/jm00015a020] |
| 22. Valli MJ, Tang Y, Kosh JW, Chapman JM, Sowell JW.. (1992) Synthesis and cholinergic properties of N-aryl-2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethylamino analogs of ranitidine., 35 (17): [PMID:1507203] [10.1021/jm00095a008] |
| 23. Birnberg G, Fanshawe W, Levin J, Epstein J, Beer B, Bartus R, Dean R. (1992) The synthesis and cognition enhancing effects of a series of dibenzoyl guanidines. Analogs of N,N-[[4-(aminocarbonyl)phenyl]carbonimidoyl]bis[benzamide], 2 (4): [10.1016/S0960-894X(01)80216-X] |
| 24. Butler DE, Poschel BP, Marriott JG.. (1981) Cognition-activating properties of 3-(Aryloxy)pyridines., 24 (3): [PMID:7265121] [10.1021/jm00135a020] |
| 25. Levin J, Fanshawe W, Epstein J, Beer B, Bartus R, Dean R. (1992) Synthesis and activity in cognition-related tests of novel 2-benzoylamino-4-oxoquinazolines, 2 (4): [10.1016/S0960-894X(01)80217-1] |
| 26. Rampa A, Piazzi L, Belluti F, Gobbi S, Bisi A, Bartolini M, Andrisano V, Cavrini V, Cavalli A, Recanatini M, Valenti P.. (2001) Acetylcholinesterase inhibitors: SAR and kinetic studies on omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl derivatives., 44 (23): [PMID:11689067] [10.1021/jm010914b] |
| 27. Tong W, Collantes ER, Chen Y, Welsh WJ.. (1996) A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors., 39 (2): [PMID:8558505] [10.1021/jm950704x] |
| 28. Rampa A, Bisi A, Valenti P, Recanatini M, Cavalli A, Andrisano V, Cavrini V, Fin L, Buriani A, Giusti P.. (1998) Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives., 41 (21): [PMID:9767635] [10.1021/jm9810046] |
| 29. Yu Q, Holloway HW, Flippen-Anderson JL, Hoffman B, Brossi A, Greig NH.. (2001) Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action., 44 (24): [PMID:11708910] [10.1021/jm010080x] |
| 30. Melchiorre C, Andrisano V, Bolognesi ML, Budriesi R, Cavalli A, Cavrini V, Rosini M, Tumiatti V, Recanatini M.. (1998) Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease., 41 (22): [PMID:9784091] [10.1021/jm9810452] |
| 31. So SS, Karplus M.. (1997) Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications., 40 (26): [PMID:9435905] [10.1021/jm970488n] |
| 32. Levin J, Epstein J, Beer B, Dean W, Dusza J, Tseng S, Schweitzer H, Francisco G, Cain W, Bartus R, Dean R. (1991) Synthesis of substituted 5-amino-8-phenyl-3H,6H-1,4,5a,8a-tetraazaacenaphthalen-3-ones, a new class of agents for the improvement of cognition., 1 (9): [10.1016/S0960-894X(01)81101-X] |
| 33. Sugimoto H, Tsuchiya Y, Sugumi H, Higurashi K, Karibe N, Iimura Y, Sasaki A, Araki S, Yamanishi Y, Yamatsu K.. (1992) Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives., 35 (24): [PMID:1469686] [10.1021/jm00102a005] |
| 34. Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K.. (1995) Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds., 38 (24): [PMID:7490731] [10.1021/jm00024a009] |
| 35. Chen YL, Hedberg K. (1991) Total synthesis of an optically active 8-carba-physostigmine analog: a potent acetylcholinesterase inhibitor, 1 (1): [10.1016/S0960-894X(01)81088-X] |
| 36. Cho SJ, Garsia ML, Bier J, Tropsha A.. (1996) Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors., 39 (26): [PMID:8978837] [10.1021/jm950771r] |
| 37. Cannon JG, Sahin MF, Long JP, Flynn JR, Bhatnagar RK.. (1990) Hemicholinium-3 congeners as potential antagonists to organophosphate-induced toxicity., 33 (2): [PMID:2153818] [10.1021/jm00164a017] |
| 38. Perola E, Cellai L, Brufani M.. (1998) Synthesis and activity studies of N-[omega-N'-(adamant-1'-yl)aminoalkyl]- 2-(4'-dimethylaminophenyl)acetamides: in the search of selective inhibitors for the different molecular forms of acetylcholinesterase., 8 (6): [PMID:9871563] [10.1016/s0960-894x(98)00076-6] |
| 39. Cardozo MG, Iimura Y, Sugimoto H, Yamanishi Y, Hopfinger AJ.. (1992) QSAR analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase., 35 (3): [PMID:1738151] [10.1021/jm00081a022] |
| 40. Vidaluc JL, Calmel F, Bigg D, Carilla E, Stenger A, Chopin P, Briley M.. (1994) Novel [2-(4-piperidinyl)ethyl](thio)ureas: synthesis and antiacetylcholinesterase activity., 37 (5): [PMID:8126709] [10.1021/jm00031a019] |
| 41. Gregor VE, Emmerling MR, Lee C, Moore CJ. (1992) The synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory activity of tacrine (Cognex) derivaties, 2 (8): [10.1016/S0960-894X(00)80545-4] |
| 42. Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K. (1992) Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compounds, 2 (8): [10.1016/S0960-894X(00)80547-8] |
| 43. Tumiatti V, Rosini M, Bartolini M, Cavalli A, Marucci G, Andrisano V, Angeli P, Banzi R, Minarini A, Recanatini M, Melchiorre C.. (2003) Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine., 46 (6): [PMID:12620072] [10.1021/jm021055+] |
| 44. Luo W, Yu QS, Zhan M, Parrish D, Deschamps JR, Kulkarni SS, Holloway HW, Alley GM, Lahiri DK, Brossi A, Greig NH.. (2005) Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine., 48 (4): [PMID:15715468] [10.1021/jm049309+] |
| 45. Mizutani MY, Itai A.. (2004) Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors., 47 (20): [PMID:15369385] [10.1021/jm030605g] |
| 46. Belluti F, Rampa A, Piazzi L, Bisi A, Gobbi S, Bartolini M, Andrisano V, Cavalli A, Recanatini M, Valenti P.. (2005) Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation., 48 (13): [PMID:15974596] [10.1021/jm049515h] |
| 47. Caron G, Ermondi G.. (2005) Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk)., 48 (9): [PMID:15857133] [10.1021/jm048980b] |
| 48. Bianchi DA, Hirschmann GS, Theoduloz C, Bracca AB, Kaufman TS.. (2005) Synthesis of tricyclic analogs of stephaoxocanidine and their evaluation as acetylcholinesterase inhibitors., 15 (11): [PMID:15878275] [10.1016/j.bmcl.2005.04.005] |
| 49. Luo W, Yu QS, Kulkarni SS, Parrish DA, Holloway HW, Tweedie D, Shafferman A, Lahiri DK, Brossi A, Greig NH.. (2006) Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine., 49 (7): [PMID:16570913] [10.1021/jm050578p] |
| 50. Schott Y, Decker M, Rommelspacher H, Lehmann J.. (2006) 6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors., 16 (22): [PMID:16945529] [10.1016/j.bmcl.2006.08.067] |
| 51. Tumiatti V, Andrisano V, Banzi R, Bartolini M, Minarini A, Rosini M, Melchiorre C.. (2004) Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties., 47 (26): [PMID:15588084] [10.1021/jm0494366] |
| 52. Muñoz-Ruiz P, Rubio L, García-Palomero E, Dorronsoro I, del Monte-Millán M, Valenzuela R, Usán P, de Austria C, Bartolini M, Andrisano V, Bidon-Chanal A, Orozco M, Luque FJ, Medina M, Martínez A.. (2005) Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease., 48 (23): [PMID:16279781] [10.1021/jm0503289] |
| 53. Moda TL, Montanari CA, Andricopulo AD.. (2007) Hologram QSAR model for the prediction of human oral bioavailability., 15 (24): [PMID:17870541] [10.1016/j.bmc.2007.08.060] |
| 54. Kalauni SK, Choudhary MI, Shaheen F, Manandhar MD, Atta-ur-Rahman, Gewali MB, Khalid A.. (2001) Steroidal alkaloids from the leaves of Sarcococca coriacea of Nepalese origin., 64 (6): [PMID:11421762] [10.1021/np000466v] |
| 55. Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F.. (2008) Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors., 51 (21): [PMID:18834112] [10.1021/jm800656v] |
| 56. Choudhary MI, Shahnaz S, Parveen S, Khalid A, Majeed Ayatollahi SA, Atta-Ur-Rahman, Parvez M.. (2003) New triterpenoid alkaloid cholinesterase inhibitors from Buxus hyrcana., 66 (6): [PMID:12828454] [10.1021/np020446o] |
| 57. Carolan CG, Dillon GP, Gaynor JM, Reidy S, Ryder SA, Khan D, Marquez JF, Gilmer JF.. (2008) Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors., 51 (20): [PMID:18817366] [10.1021/jm800564y] |
| 58. Singh DK, Agarwal RA.. (1984) Correlation of the anticholinesterase and molluscicidal activity of the latex of Euphorbia royleana on the snail Lymnaea acuminata., 47 (4): [PMID:6491683] [10.1021/np50034a023] |
| 59. Mroue MA, Euler KL, Ghuman MA, Alam M. (1996) Indole Alkaloids of Haplophyton crooksii 1 , 59 (9): [10.1021/np960070c] |
| 60. Mungkornasawakul P, Chaiyong S, Sastraruji T, Jatisatienr A, Jatisatienr C, Pyne SG, Ung AT, Korth J, Lie W.. (2009) Alkaloids from the roots of Stemona aphylla., 72 (5): [PMID:19374387] [10.1021/np900030y] |
| 61. Baird MC, Pyne SG, Ung AT, Lie W, Sastraruji T, Jatisatienr A, Jatisatienr C, Dheeranupattana S, Lowlam J, Boonchalermkit S.. (2009) Semisynthesis and biological activity of stemofoline alkaloids., 72 (4): [PMID:19222234] [10.1021/np800806b] |
| 62. Carolan CG, Dillon GP, Khan D, Ryder SA, Gaynor JM, Reidy S, Marquez JF, Jones M, Holland V, Gilmer JF.. (2010) Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor., 53 (3): [PMID:20067290] [10.1021/jm9014845] |
| 63. Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD.. (2010) Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination., 53 (3): [PMID:20070106] [10.1021/jm901371v] |
| 64. Geissler T, Brandt W, Porzel A, Schlenzig D, Kehlen A, Wessjohann L, Arnold N.. (2010) Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus., 18 (6): [PMID:20176490] [10.1016/j.bmc.2010.01.074] |
| 65. Vincent F, Nguyen MT, Emerling DE, Kelly MG, Duncton MA.. (2009) Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors., 19 (23): [PMID:19850474] [10.1016/j.bmcl.2009.09.086] |
| 66. Vincent F, Nguyen MT, Emerling DE, Kelly MG, Duncton MA.. (2009) Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors., 19 (23): [PMID:19850474] [10.1016/j.bmcl.2009.09.086] |
| 67. Zhan ZJ, Bian HL, Wang JW, Shan WG.. (2010) Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities., 20 (5): [PMID:20144867] [10.1016/j.bmcl.2010.01.097] |
| 68. Takahashi J, Hijikuro I, Kihara T, Murugesh MG, Fuse S, Tsumura Y, Akaike A, Niidome T, Takahashi T, Sugimoto H.. (2010) Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors., 20 (5): [PMID:20137941] [10.1016/j.bmcl.2010.01.035] |
| 69. Takahashi J, Hijikuro I, Kihara T, Murugesh MG, Fuse S, Kunimoto R, Tsumura Y, Akaike A, Niidome T, Okuno Y, Takahashi T, Sugimoto H.. (2010) Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors., 20 (5): [PMID:20137934] [10.1016/j.bmcl.2010.01.057] |
| 70. Serrano MA, Pivatto M, Francisco W, Danuello A, Regasini LO, Lopes EM, Lopes MN, Young MC, Bolzani VS.. (2010) Acetylcholinesterase inhibitory pyridine alkaloids of the leaves of Senna multijuga., 73 (3): [PMID:20000694] [10.1021/np900644x] |
| 71. Rosenbaum AI, Cosner CC, Mariani CJ, Maxfield FR, Wiest O, Helquist P.. (2010) Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics., 53 (14): [PMID:20557099] [10.1021/jm100499s] |
| 72. Yu QS, Holloway HW, Luo W, Lahiri DK, Brossi A, Greig NH.. (2010) Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine., 18 (13): [PMID:20627738] [10.1016/j.bmc.2010.05.022] |
| 73. Kokel D, Bryan J, Laggner C, White R, Cheung CY, Mateus R, Healey D, Kim S, Werdich AA, Haggarty SJ, Macrae CA, Shoichet B, Peterson RT.. (2010) Rapid behavior-based identification of neuroactive small molecules in the zebrafish., 6 (3): [PMID:20081854] [10.1038/nchembio.307] |
| 74. Chaudhaery SS, Roy KK, Shakya N, Saxena G, Sammi SR, Nazir A, Nath C, Saxena AK.. (2010) Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology., 53 (17): [PMID:20684567] [10.1021/jm100573q] |
| 75. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.. (2007) Chemical genetics reveals a complex functional ground state of neural stem cells., 3 (5): [PMID:17417631] [10.1038/nchembio873] |
| 76. Yuan J, Johnson RL, Huang R, Wichterman J, Jiang H, Hayton K, Fidock DA, Wellems TE, Inglese J, Austin CP, Su XZ.. (2009) Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum., 5 (10): [PMID:19734910] [10.1038/nchembio.215] |
| 77. PubChem BioAssay data set, |
| 78. PubChem BioAssay data set, |
| 79. Pelletier DJ, Gehlhaar D, Tilloy-Ellul A, Johnson TO, Greene N.. (2007) Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential., 47 (1): [PMID:17428028] [10.1021/ci6004542] |
| 80. Lowe R, Glen RC, Mitchell JB.. (2010) Predicting phospholipidosis using machine learning., 7 (5): [PMID:20799726] [10.1021/mp100103e] |
| 81. Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ.. (2010) Developing structure-activity relationships for the prediction of hepatotoxicity., 23 (7): [PMID:20553011] [10.1021/tx1000865] |
| 82. Ekins S, Williams AJ, Xu JJ.. (2010) A predictive ligand-based Bayesian model for human drug-induced liver injury., 38 (12): [PMID:20843939] [10.1124/dmd.110.035113] |
| 83. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 84. PubChem BioAssay data set, |
| 85. PubChem BioAssay data set, |
| 86. PubChem BioAssay data set, |
| 87. PubChem BioAssay data set, |
| 88. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
| 89. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 90. Cho JK, Ryu YB, Curtis-Long MJ, Ryu HW, Yuk HJ, Kim DW, Kim HJ, Lee WS, Park KH.. (2012) Cholinestrase inhibitory effects of geranylated flavonoids from Paulownia tomentosa fruits., 20 (8): [PMID:22445674] [10.1016/j.bmc.2012.02.044] |
| 91. Francisco W, Pivatto M, Danuello A, Regasini LO, Baccini LR, Young MC, Lopes NP, Lopes JL, Bolzani VS.. (2012) Pyridine alkaloids from Senna multijuga as acetylcholinesterase inhibitors., 75 (3): [PMID:22304303] [10.1021/np200814j] |
| 92. Shinada M, Narumi F, Osada Y, Matsumoto K, Yoshida T, Higuchi K, Kawasaki T, Tanaka H, Satoh M.. (2012) Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities., 20 (16): [PMID:22831800] [10.1016/j.bmc.2012.06.048] |
| 93. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 94. Darras FH, Kling B, Heilmann J, Decker M.. (2012) Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer., 3 (11): [PMID:24900407] [10.1021/ml3001825] |
| 95. Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P.. (2012) Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine., 20 (22): [PMID:23062825] [10.1016/j.bmc.2012.09.040] |
| 96. Yang Z, Zhang D, Ren J, Yang M. (2012) Skimmianine, a furoquinoline alkaloid from Zanthoxylum nitidum as a potential acetylcholinesterase inhibitor, 21 (6): [10.1007/s00044-011-9581-9] |
| 97. Ciftci GA, Temel HE, Yldrm SU, Kaplanckl ZA, Altntop MD, Genc L. (2013) Apoptotic effects of some carbazole derivatives on lung carcinoma and glioma cell lines, 22 (8): [10.1007/s00044-012-0325-2] |
| 98. PubChem BioAssay data set, |
| 99. Ben Salem S, Jabrane A, Harzallah-Skhiri F, Ben Jannet H.. (2013) New bioactive dihydrofuranocoumarins from the roots of the Tunisian Ferula lutea (Poir.) Maire., 23 (14): [PMID:23746477] [10.1016/j.bmcl.2013.04.081] |
| 100. Mumtaz S, Hussain R, Rauf A, Fatmi MQ, Bokhari H, Oelgemoller M, Qureshi AM. (2013) Synthesis, molecular docking studies, and in vitro screening of barbiturates/thiobarbiturates as antibacterial and cholinesterase inhibitors, [10.1007/s00044-013-0847-2] |
| 101. Settimo L, Bellman K, Knegtel RM.. (2013) Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds., [PMID:24249037] [10.1007/s11095-013-1232-z] |
| 102. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6): [PMID:23571415] [10.1124/mol.112.084152] |
| 103. PubChem BioAssay data set, |
| 104. Vina D, Matos MJ, Yanez M, Santana L, Uriarte E. (2012) 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease, 3 (2): [10.1039/C1MD00221J] |
| 105. Rodger IW, Hersom AS, Waigh RD.. (1979) Actions of two dopamine derivatives at adreno- and cholinoceptors., 22 (1): [PMID:423175] [10.1021/jm00187a027] |
| 106. Jabeen F, Oliferenko PV, Oliferenko AA, Pillai GG, Ansari FL, Hall CD, Katritzky AR.. (2014) Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis., 80 [PMID:24780600] [10.1016/j.ejmech.2014.04.018] |
| 107. Huang G, Kling B, Darras FH, Heilmann J, Decker M.. (2014) Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine., 81 [PMID:24819955] [10.1016/j.ejmech.2014.05.002] |
| 108. Castro MJ, Richmond V, Romero C, Maier MS, Estévez-Braun A, Ravelo AG, Faraoni MB, Murray AP.. (2014) Preparation, anticholinesterase activity and molecular docking of new lupane derivatives., 22 (13): [PMID:24835788] [10.1016/j.bmc.2014.04.050] |
| 109. Darras FH, Kling B, Sawatzky E, Heilmann J, Decker M.. (2014) Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase., 22 (17): [PMID:25059502] [10.1016/j.bmc.2014.06.010] |
| 110. Dawson S, Stahl S, Paul N, Barber J, Kenna JG.. (2012) In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans., 40 (1): [PMID:21965623] [10.1124/dmd.111.040758] |
| 111. PubChem BioAssay data set, |
| 112. Mehr-un-Nisa, Munawar MA, Chattha FA, Kousar S, Munir J, Ismail T, Ashraf M, Khan MA.. (2015) Synthesis of novel triazoles and a tetrazole of escitalopram as cholinesterase inhibitors., 23 (17): [PMID:26189031] [10.1016/j.bmc.2015.06.051] |
| 113. Sawatzky E, Wehle S, Kling B, Wendrich J, Bringmann G, Sotriffer CA, Heilmann J, Decker M.. (2016) Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode., 59 (5): [PMID:26886849] [10.1021/acs.jmedchem.5b01674] |
| 114. Abdul Wahab SM, Sivasothy Y, Liew SY, Litaudon M, Mohamad J, Awang K.. (2016) Natural cholinesterase inhibitors from Myristica cinnamomea King., 26 (15): [PMID:27236720] [10.1016/j.bmcl.2016.05.046] |
| 115. Wan Othman WN, Liew SY, Khaw KY, Murugaiyah V, Litaudon M, Awang K.. (2016) Cholinesterase inhibitory activity of isoquinoline alkaloids from three Cryptocarya species (Lauraceae)., 24 (18): [PMID:27492195] [10.1016/j.bmc.2016.07.043] |
| 116. Montanari S, Scalvini L, Bartolini M, Belluti F, Gobbi S, Andrisano V, Ligresti A, Di Marzo V, Rivara S, Mor M, Bisi A, Rampa A.. (2016) Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents., 59 (13): [PMID:27309570] [10.1021/acs.jmedchem.6b00609] |
| 117. WHO Anatomical Therapeutic Chemical Classification, |
| 118. DrugMatrix, [10.6019/CHEMBL3885881] |
| 119. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 120. Nisa MU, Munawar MA, Iqbal A, Ahmed A, Ashraf M, Gardener QA, Khan MA.. (2017) Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors., 138 [PMID:28688279] [10.1016/j.ejmech.2017.06.036] |
| 121. Gurjar AS, Darekar MN, Yeong KY, Ooi L.. (2018) In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease., 26 (8): [PMID:29429576] [10.1016/j.bmc.2018.01.029] |
| 122. Unpublished dataset, |
| 123. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson. (2020) Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2, [10.1101/2020.04.21.054387] |
| 124. Dargó G, Bajusz D, Simon K, Müller J, Balogh GT.. (2020) Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design., 63 (4): [PMID:31995375] [10.1021/acs.jmedchem.0c00046] |
| 125. Xu M, Peng Y, Zhu L, Wang S, Ji J, Rakesh KP.. (2019) Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships., 180 [PMID:31352246] [10.1016/j.ejmech.2019.07.059] |
| 126. Torres FR, Pérez-Castorena AL, Arredondo L, Toscano RA, Nieto-Camacho A, Martínez M, Maldonado E.. (2019) Labdanes, Withanolides, and Other Constituents from Physalis nicandroides., 82 (9): [PMID:31429569] [10.1021/acs.jnatprod.9b00233] |
| 127. Dai W, Sandoval IT, Cai S, Smith KA, Delacruz RGC, Boyd KA, Mills JJ, Jones DA, Cichewicz RH.. (2019) Cholinesterase Inhibitory Arisugacins L-Q from a Penicillium sp. Isolate Obtained through a Citizen Science Initiative and Their Activities in a Phenotype-Based Zebrafish Assay., 82 (9): [PMID:31433188] [10.1021/acs.jnatprod.9b00563] |
| 128. Rios MY, Ocampo-Acuña YD, Ramírez-Cisneros MÁ, Salazar-Rios ME.. (2020) Furofuranone Lignans from Leucophyllum ambiguum., 83 (5): [PMID:32239935] [10.1021/acs.jnatprod.9b00759] |
| 129. Maříková J, Ritomská A, Korábečný J, Peřinová R, Al Mamun A, Kučera T, Kohelová E, Hulcová D, Kobrlová T, Kuneš J, Nováková L, Cahlíková L.. (2020) Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase., 83 (5): [PMID:32309949] [10.1021/acs.jnatprod.9b00561] |
| 130. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 131. Lin SX,Curtis MA,Sperry J. (2020) Pyridine alkaloids with activity in the central nervous system., 28 (24): [PMID:33120080] [10.1016/j.bmc.2020.115820] |
| 132. Osella, M. I., Salazar, M. O., Gamarra, M. D., Moreno, D. M., Lambertucci, F., Frances, D. E., Furlan, R. L. E.. (2020) Arylsulfonyl histamine derivatives as powerful and selective alpha-glucosidase inhibitors, 11 (4): [PMID:33479653] [10.1039/c9md00559e] |
| 133. Santi MD,Arredondo F,Carvalho D,Echeverry C,Prunell G,Peralta MA,Cabrera JL,Ortega MG,Savio E,Abin-Carriquiry JA. (2020) Neuroprotective effects of prenylated flavanones isolated from Dalea species, in vitro and in silico studies., 206 [PMID:32861919] [10.1016/j.ejmech.2020.112718] |
| 134. Maafi N, Pidaný F, Maříková J, Korábečný J, Hulcová D, Kučera T, Schmidt M, Shammari LA, Špulák M, Carmen Catapano M, Mecava M, Prchal L, Kuneš J, Janoušek J, Kohelová E, Jenčo J, Nováková L, Cahlíková L.. (2021) Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study., 51 [PMID:34555506] [10.1016/j.bmcl.2021.128374] |
| 135. Liu D, Zhang H, Wang Y, Liu W, Yin G, Wang D, Li J, Shi T, Wang Z.. (2022) Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease., 229 [PMID:34923430] [10.1016/j.ejmech.2021.114044] |
| 136. Machado V, Cenci AR, Teixeira KF, Sens L, Tizziani T, Nunes RJ, Ferreira LLG, Yunes RA, Sandjo LP, Andricopulo AD, de Oliveira AS.. (2022) Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies., 13 (12.0): [PMID:36561075] [10.1039/d2md00262k] |
| 137. Zhang H, Wang Y, Wang Y, Li X, Wang S, Wang Z.. (2022) Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease., 240 [PMID:35858523] [10.1016/j.ejmech.2022.114606] |
| 138. Ferreira JPS, Albuquerque HMT, Cardoso SM, Silva AMS, Silva VLM.. (2021) Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR)., 221 [PMID:33984802] [10.1016/j.ejmech.2021.113492] |
| 139. Gonçalves GA, Spillere AR, das Neves GM, Kagami LP, von Poser GL, Canto RFS, Eifler-Lima V.. (2020) Natural and synthetic coumarins as antileishmanial agents: A review., 203 [PMID:32668302] [10.1016/j.ejmech.2020.112514] |
| 140. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
